TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites April 24, 1981